Skip to main content
. 2011 Aug 12;118(15):4024–4035. doi: 10.1182/blood-2011-05-351346

Table 5.

Recommendations for the treatment (standard therapies) of CD30+ LPD

PCALCL
LYP
Solitary or grouped lesion(s) Multifocal lesions Extracutaneous spread Localized/regional or few lesions* Numerous and/or generalized lesions
SE Methotrexate Single or multiagent chemotherapy Observation Observation
RT Alternatives: retinoids, interferon Phototherapy§ Phototherapy§
Topical steroids Methotrexate
Topical steroids
Alternatives: retinoids, interferon
*

For larger (defined as > 2 cm in diameter) and persistent (defined as duration of lesion > 12 weeks) lesions, SE or RT may represent alternatives.

These therapies are of low-level evidence other than expert opinion.

In cases of skin and only local node involvement in PCALCL, one could consider addition of local nodal radiation 4

§

PUVA is best documented. Alternatively, treatment with other types of phototherapy (eg, UVB-narrow band) can be tried (evidence level 5).